to its critics, ephedra is a potentially dangerous substance that urgently needs more study and regulation.
Drugs containing ephedra vulgaris, drug-making chemicals and mental medicines increased notably in 1997.
Critics and proponents alike agree on one thing: ephedra is flying off the shelves.
Ms. Capati, who suffered from high blood pressure, had been taking Thermadrene, an ephedra supplement manufactured by SportPharma of Concord, Calif.
The agency also is looking at requiring product labels that instruct consumers not to use the product for more than seven days.
If the products were safe, companies could say what they wished, so long as
